Cargando…

Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma

Mutations in the cornified cell envelope protein loricrin have been reported recently in some patients with Vohwinkel syndrome (VS) and progressive symmetric erythrokeratoderma (PSEK). To establish a causative relationship between loricrin mutations and these diseases, we have generated transgenic m...

Descripción completa

Detalles Bibliográficos
Autores principales: Suga, Yasushi, Jarnik, Michal, Attar, Paul S., Longley, Mary A., Bundman, Donnie, Steven, Alasdair C., Koch, Peter J., Roop, Dennis R.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192631/
https://www.ncbi.nlm.nih.gov/pubmed/11038186
_version_ 1782147284429963264
author Suga, Yasushi
Jarnik, Michal
Attar, Paul S.
Longley, Mary A.
Bundman, Donnie
Steven, Alasdair C.
Koch, Peter J.
Roop, Dennis R.
author_facet Suga, Yasushi
Jarnik, Michal
Attar, Paul S.
Longley, Mary A.
Bundman, Donnie
Steven, Alasdair C.
Koch, Peter J.
Roop, Dennis R.
author_sort Suga, Yasushi
collection PubMed
description Mutations in the cornified cell envelope protein loricrin have been reported recently in some patients with Vohwinkel syndrome (VS) and progressive symmetric erythrokeratoderma (PSEK). To establish a causative relationship between loricrin mutations and these diseases, we have generated transgenic mice expressing a COOH-terminal truncated form of loricrin that is similar to the protein expressed in VS and PSEK patients. At birth, transgenic mice (ML.VS) exhibited erythrokeratoderma with an epidermal barrier dysfunction. 4 d after birth, high-expressing transgenic animals showed a generalized scaling of the skin, as well as a constricting band encircling the tail and, by day 7, a thickening of the footpads. Histologically, ML.VS transgenic mice also showed retention of nuclei in the stratum corneum, a characteristic feature of VS and PSEK. Immunofluorescence and immunoelectron microscopy showed the mutant loricrin protein in the nucleus and cytoplasm of epidermal keratinocytes, but did not detect the protein in the cornified cell envelope. Transfection experiments indicated that the COOH-terminal domain of the mutant loricrin contains a nuclear localization signal. To determine whether the ML.VS phenotype resulted from dominant-negative interference of the transgene with endogenous loricrin, we mated the ML.VS transgenics with loricrin knockout mice. A severe phenotype was observed in mice that lacked expression of wild-type loricrin. Since loricrin knockout mice are largely asymptomatic (Koch, P.K., P.A. de Viragh, E. Scharer, D. Bundman, M.A. Longley, J. Bickenbach, Y. Kawachi, Y. Suga, Z. Zhou, M. Huber, et al., J. Cell Biol. 151:389–400, this issue), this phenotype may be attributed to expression of the mutant form of loricrin. Thus, deposition of the mutant protein in the nucleus appears to interfere with late stages of epidermal differentiation, resulting in a VS-like phenotype.
format Text
id pubmed-2192631
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21926312008-05-01 Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma Suga, Yasushi Jarnik, Michal Attar, Paul S. Longley, Mary A. Bundman, Donnie Steven, Alasdair C. Koch, Peter J. Roop, Dennis R. J Cell Biol Original Article Mutations in the cornified cell envelope protein loricrin have been reported recently in some patients with Vohwinkel syndrome (VS) and progressive symmetric erythrokeratoderma (PSEK). To establish a causative relationship between loricrin mutations and these diseases, we have generated transgenic mice expressing a COOH-terminal truncated form of loricrin that is similar to the protein expressed in VS and PSEK patients. At birth, transgenic mice (ML.VS) exhibited erythrokeratoderma with an epidermal barrier dysfunction. 4 d after birth, high-expressing transgenic animals showed a generalized scaling of the skin, as well as a constricting band encircling the tail and, by day 7, a thickening of the footpads. Histologically, ML.VS transgenic mice also showed retention of nuclei in the stratum corneum, a characteristic feature of VS and PSEK. Immunofluorescence and immunoelectron microscopy showed the mutant loricrin protein in the nucleus and cytoplasm of epidermal keratinocytes, but did not detect the protein in the cornified cell envelope. Transfection experiments indicated that the COOH-terminal domain of the mutant loricrin contains a nuclear localization signal. To determine whether the ML.VS phenotype resulted from dominant-negative interference of the transgene with endogenous loricrin, we mated the ML.VS transgenics with loricrin knockout mice. A severe phenotype was observed in mice that lacked expression of wild-type loricrin. Since loricrin knockout mice are largely asymptomatic (Koch, P.K., P.A. de Viragh, E. Scharer, D. Bundman, M.A. Longley, J. Bickenbach, Y. Kawachi, Y. Suga, Z. Zhou, M. Huber, et al., J. Cell Biol. 151:389–400, this issue), this phenotype may be attributed to expression of the mutant form of loricrin. Thus, deposition of the mutant protein in the nucleus appears to interfere with late stages of epidermal differentiation, resulting in a VS-like phenotype. The Rockefeller University Press 2000-10-16 /pmc/articles/PMC2192631/ /pubmed/11038186 Text en © 2000 The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Original Article
Suga, Yasushi
Jarnik, Michal
Attar, Paul S.
Longley, Mary A.
Bundman, Donnie
Steven, Alasdair C.
Koch, Peter J.
Roop, Dennis R.
Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma
title Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma
title_full Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma
title_fullStr Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma
title_full_unstemmed Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma
title_short Transgenic Mice Expressing a Mutant Form of Loricrin Reveal the Molecular Basis of the Skin Diseases, Vohwinkel Syndrome and Progressive Symmetric Erythrokeratoderma
title_sort transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, vohwinkel syndrome and progressive symmetric erythrokeratoderma
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192631/
https://www.ncbi.nlm.nih.gov/pubmed/11038186
work_keys_str_mv AT sugayasushi transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma
AT jarnikmichal transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma
AT attarpauls transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma
AT longleymarya transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma
AT bundmandonnie transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma
AT stevenalasdairc transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma
AT kochpeterj transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma
AT roopdennisr transgenicmiceexpressingamutantformofloricrinrevealthemolecularbasisoftheskindiseasesvohwinkelsyndromeandprogressivesymmetricerythrokeratoderma